These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15899079)

  • 1. Treatment failure of vaginal trichomoniasis in clinical practice.
    Das S; Huengsberg M; Shahmanesh M
    Int J STD AIDS; 2005 Apr; 16(4):284-6. PubMed ID: 15899079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoxynol 9 as an additive therapy in metronidazole-resistant cases of vaginal trichomoniasis.
    El Bassiouni SO; Riad RM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):551-62. PubMed ID: 16083067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant trichomoniasis: successful treatment with combination therapy.
    Nyirjesy P; Gilbert J; Mulcahy LJ
    Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
    Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
    Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
    Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.
    Wood S; Kennedy CM; Galask RP
    J Reprod Med; 2007 Nov; 52(11):1057-8. PubMed ID: 18161407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole for the treatment of vaginal infections.
    Sobel R; Sobel JD
    Expert Opin Pharmacother; 2015 May; 16(7):1109-15. PubMed ID: 25887246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent vaginitis caused by metronidazole-resistant trichomonas.
    Grossman JH; Galask RP
    Obstet Gynecol; 1990 Sep; 76(3 Pt 2):521-2. PubMed ID: 2381638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Attitudes for Belgian Women With Persistent Trichomonas vaginalis Infection in the VlaResT Study.
    Donders GGG; Ruban K; Depuydt C; Bellen G; Vanden Broeck D; Jonckheere J; Jacquemyn Y
    Clin Infect Dis; 2019 Apr; 68(9):1575-1580. PubMed ID: 30395193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis].
    Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R
    Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Klion suspension in paediatry and gynaecology.
    Takács G
    Ther Hung; 1992; 40(4):189-91. PubMed ID: 1345028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic options for the treatment of human trichomoniasis.
    Küng E; Fürnkranz U; Walochnik J
    Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole-Resistant Trichomoniasis: Beneficial Pharmacodynamic Relationship With High-Dose Oral Tinidazole and Vaginal Paromomycin Combination Therapy.
    Henien M; Nyirjesy P; Smith K
    Sex Transm Dis; 2019 Jan; 46(1):e1-e2. PubMed ID: 30106840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vaginal trichomoniasis with a new anti-protozoal compound ( -chloromethyl-2-methyl-5-nitro-1-imidazole-ethanol).
    Lean TH; Vengadasalam D
    Br J Vener Dis; 1973 Feb; 49(1):69-71. PubMed ID: 4348437
    [No Abstract]   [Full Text] [Related]  

  • 19. An investigation, by questionnaire, of cases of recalcitrant vaginal trichomoniasis seen in genitourinary medicine clinics in the United Kingdom. British Co-operative Clinical Group.
    Int J STD AIDS; 1992; 3(1):24-7. PubMed ID: 1543763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report.
    Tayal S
    Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.